(MENAFN- JCN NewsWire) New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF TOKYO and CAMBRIDGE, Mass., Dec 3, 2025 - ...
Cognito Therapeutics Announces Presentation of New CSF Proteomic and EEG Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025 Cognito Therapeutics, a clinical-stage medical device company ...
TOKYO and CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai”) and Biogen Inc. (Nasdaq: BIIB ...
AD is a progressive, relentless disease with Aβ and tau as hallmarks. It is caused by a continuous underlying neurotoxic process driven by PF that begins before amyloid plaque accumulation and ...
Plus Therapeutics, Inc. announced that its subsidiary, CNSide Diagnostics, will present data at the SNO/ASCO CNS Metastases Conference from August 14-16, 2025, in Baltimore, MD. The presentations will ...
It is not possible to test for a cerebrospinal fluid (CSF) leak at home. However, knowing the possible symptoms of a CSF leak can help a person know when to seek emergency help to receive a diagnosis ...
Scientists at the Institute for Basic Science (IBS) have uncovered a non-invasive method to boost the brain’s natural waste drainage system—a discovery that they suggest could open new avenues for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback